We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SYNTHON, GSK SETTLE DISPUTE OVER NEW PAROXETINE DRUG
SYNTHON, GSK SETTLE DISPUTE OVER NEW PAROXETINE DRUG
January 27, 2004
Generic firm Synthon is free to launch a variation of GlaxoSmithKline’s (GSK’s) profitable antidepressant Paxil (paroxetine HCl) after the firms settled a patent dispute over the drug.